| Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone JJ Nolan, B Ludvik, P Beerdsen, M Joyce, J Olefsky New England Journal of Medicine 331 (18), 1188-1193, 1994 | 1210 | 1994 |
| A model-based method for assessing insulin sensitivity from the oral glucose tolerance test A Mari, G Pacini, E Murphy, B Ludvik, JJ Nolan Diabetes care 24 (3), 539-548, 2001 | 937 | 2001 |
| The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus E Cauza, U Hanusch-Enserer, B Strasser, B Ludvik, S Metz-Schimmerl, ... Archives of physical medicine and rehabilitation 86 (8), 1527-1533, 2005 | 733 | 2005 |
| Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels FB Langer, MA Reza Hoda, A Bohdjalian, FX Felberbauer, J Zacherl, ... Obesity surgery 15 (7), 1024-1029, 2005 | 718 | 2005 |
| 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial CW Le Roux, A Astrup, K Fujioka, F Greenway, DCW Lau, L Van Gaal, ... The Lancet 389 (10077), 1399-1409, 2017 | 702 | 2017 |
| Sleeve Gastrectomy as Sole and Definitive Bariatric Procedure: 5-Year Results for Weight Loss and Ghrelin A Bohdjalian, FB Langer, S Shakeri-Leidenmühler, L Gfrerer, B Ludvik, ... Obesity surgery 20, 535-540, 2010 | 658 | 2010 |
| Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding DG Haider, K Schindler, G Schaller, G Prager, M Wolzt, B Ludvik The Journal of Clinical Endocrinology & Metabolism 91 (4), 1578-1581, 2006 | 514 | 2006 |
| CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity J Huber, FW Kiefer, M Zeyda, B Ludvik, GR Silberhumer, G Prager, ... The journal of clinical endocrinology & metabolism 93 (8), 3215-3221, 2008 | 429 | 2008 |
| Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised … B Ludvik, F Giorgino, E Jódar, JP Frias, LF Landó, K Brown, R Bray, ... The Lancet 398 (10300), 583-598, 2021 | 362 | 2021 |
| Pronounced insulin resistance and inadequate β-cell secretion characterize lean gestational diabetes during and after pregnancy A Kautzky-Willer, R Prager, W Waldhäusl, G Pacini, K Thomaseth, ... Diabetes care 20 (11), 1717-1723, 1997 | 335 | 1997 |
| Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? FB Langer, A Bohdjalian, FX Felberbauer, E Fleischmann, MA Reza Hoda, ... Obesity surgery 16 (2), 166-171, 2006 | 306 | 2006 |
| Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects DG Haider, K Schindler, G Prager, A Bohdjalian, A Luger, M Wolzt, ... The Journal of Clinical Endocrinology & Metabolism 92 (3), 1168-1171, 2007 | 286 | 2007 |
| Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study K Khunti, S Alsifri, R Aronson, M Cigrovski Berković, C Enters‐Weijnen, ... Diabetes, obesity and metabolism 18 (9), 907-915, 2016 | 282 | 2016 |
| Increased plasma leptin in gestational diabetes A Kautzky-Willer, G Pacini, A Tura, C Bieglmayer, B Schneider, B Ludvik, ... Diabetologia 44, 164-172, 2001 | 282 | 2001 |
| Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial B Zinman, V Bhosekar, R Busch, I Holst, B Ludvik, D Thielke, J Thrasher, ... The lancet Diabetes & endocrinology 7 (5), 356-367, 2019 | 278 | 2019 |
| Dulaglutide as add-on therapy to SGLT2 inhibitors in patients with inadequately controlled type 2 diabetes (AWARD-10): a 24-week, randomised, double-blind, placebo-controlled trial B Ludvik, JP Frías, FJ Tinahones, J Wainstein, H Jiang, KE Robertson, ... The lancet Diabetes & endocrinology 6 (5), 370-381, 2018 | 245 | 2018 |
| Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans E Hartter, T Svoboda, B Ludvik, M Schuller, B Lell, E Kuenburg, ... Diabetologia 34, 52-54, 1991 | 231 | 1991 |
| Effect of obesity on insulin resistance in normal subjects and patients with NIDDM B Ludvik, JJ Nolan, J Baloga, D Sacks, J Olefsky Diabetes 44 (9), 1121-1125, 1995 | 227 | 1995 |
| Feasibility of a mobile phone-based data service for functional insulin treatment of type 1 diabetes mellitus patients A Kollmann, M Riedl, P Kastner, G Schreier, B Ludvik Journal of medical Internet research 9 (5), e936, 2007 | 213 | 2007 |
| Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations FW Kiefer, M Zeyda, J Todoric, J Huber, R Geyeregger, T Weichhart, ... Endocrinology 149 (3), 1350-1357, 2008 | 202 | 2008 |
